Biologics News

We have had many educators in our professional and personal lives. The most influential ones have become permanent fixtures in all that we do, inspiring our best work and influencing how we live our lives.

Despite vaccine availability and the reopening of clinical offices after the onset of the COVID-19 pandemic, telehealth remains a popular choice for orthopedic patients, according to published results.

Bone marrow aspirate concentrate augmentation of the bone-patellar tendon-bone allograft during ACL reconstruction may yield greater signal intensity scores on MRI at 3 months postoperatively, according to published results.

For the 13th straight year, Hospital for Special Surgery has been named the top hospital in the United States for orthopedic care, according to the U.S. News & World Report “Best Hospitals 2022-2023” survey.

Compared with placebo, viscosupplementation provided a small reduction in pain but increased risk of serious adverse events in patients with knee osteoarthritis, according to published results.

Published results showed long delays between two-stage cell-based cartilage restoration surgeries with either autologous chondrocyte implantation or matrix autologous chondrocyte implantation may put patients at risk for defect expansion.

Social media allows people to share, inform and highlight information. Social media platforms have unique “personalities” and goals, and participation in social media is a daily activity for most people.

Repeated leukocyte-poor platelet-rich plasma injections during and after double-row suture-bridge arthroscopic rotator cuff repair may reduce the retear rate and improve Goutallier grade and clinical outcomes, according to study results.

Published results showed intraoperative injection of autologous microfragmented adipose tissue may safely and effectively improve short-term clinical and functional outcomes after single-row arthroscopic rotator cuff repair.

Published results showed intra-articular injections of leukocyte-rich platelet-rich plasma had similar clinical improvements as leukocyte-poor PRP injections in patients with symptomatic knee osteoarthritis.